Scimplify helps companies develop and manufacture speciality chemicals. The Bengaluru-based startup has raised USD 25 million in a funding round led by Hitachi Ventures.
The round drew strategic investors including Teknor Apex, Henkel and a Japanese chemical company. Existing backers Accel, 3one4 Capital, Bertelsmann India Investments and Omnivore also participated.
Read More: Jio Platforms IPO To Open For Subscription On October 21
Read More: Fintech SaaS Startup Revrag.ai Raises $2.5 Million To Build AI Relationship Managers
With this raise, Scimplify has now secured about USD 80 million in funding.
What The Money Is For
Scimplify will expand its research laboratories with the fresh capital. It also plans to deepen its presence in the United States and Europe.
A large part of the money goes into SciNode, the company’s in-house artificial intelligence platform. SciNode supports the journey from chemical discovery through to large-scale production.
Who Invested
The investors in this round are strategic rather than purely financial. Scimplify co-founder Sachin Santhosh told Mint that Hitachi, Teknor Apex and Henkel are also customers. He said a Japanese company would be announced as an investor soon.
That structure is unusual. Backers who buy the chemical already know the supply chain problem the company is trying to solve.
Where The Revenue Comes From
Overseas markets already contribute about half of Scimplify’s revenue. The company expects that share to grow further over the coming year, which explains the push into the US and Europe.
The demand is coming from supply chain diversification as much as from growth. Companies want alternatives to single-source chemical supply, particularly for materials used in batteries and semiconductors.
Scimplify says it is seeing increased traction across energy and electronics supply chains. Batteries and semiconductors are the sharpest examples, and both are moving on the AI build-out. Aerospace and defence, along with chemicals used in consumer products, are the other areas the company points to.
The Wider Trend
Funding in India’s manufacturing startups has grown sharply. It rose from USD 164 million in 2020 to USD 1.92 billion in 2026, according to data platform Venture Intelligence.
A policy push and the current geopolitical situation are both factors. Supply chains are being rebuilt with more than cost in mind. That has opened room for companies that sit between chemical discovery and factory production.
Scimplify’s pitch is that this gap is technical rather than commercial. Taking a speciality chemical from a lab result to commercial volume is slow and specialised work. That is the layer the company sells into.